News & Events :: SCYNEXIS, Inc. (SCYX)

Skip to main content Skip to section navigation Skip to footer

Recent News

Mar 31, 2026 6:45am EDT

SCYNEXIS Announces $40.0 Million Private Placement

Mar 31, 2026 6:40am EDT

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Latest Presentation

View All Presentations

Mar 31, 2026

Investor Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings